AZN vs GBCI · P/E 28, $288.38B cap vs P/E 23, rev $55.0M
AstraZeneca PLC (AZN) versus Glacier Bancorp Inc (GBCI) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
Glacier Bancorp Inc (GBCI) is a banks - regional company listed on NYSE.
AZN does not have a complete income-statement cache yet.
Latest reported GBCI revenue for 2026-06-30 was $55.0M. Net income was $180.0M. GBCI currently screens at market cap $6.27B and trailing P/E 22.5.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. GBCI currently screens at market cap $6.27B and trailing P/E 22.5.
Not investment advice. Open the AZN and GBCI stock pages for the full models.
Not investment advice.